Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
An update from SRx Health Solutions ( (SRXH) ) is now available.
SRx Health Solutions, through its Canadian subsidiary SRx Canada, is undergoing creditor protection under the Companies’ Creditors Arrangement Act (CCAA) as of August 2025. The Ontario Superior Court of Justice is overseeing the proceedings, and by September 15, 2025, most of SRx Canada’s assets have been sold through court-approved transactions, expected to close in the coming weeks.
The most recent analyst rating on (SRXH) stock is a Hold with a $0.50 price target. To see the full list of analyst forecasts on SRx Health Solutions stock, see the SRXH Stock Forecast page.
Spark’s Take on SRXH Stock
According to Spark, TipRanks’ AI Analyst, SRXH is a Neutral.
SRXH faces significant financial challenges, with declining revenues and negative cash flows being major concerns. Technical indicators also suggest bearish momentum. However, the recent earnings call provided some optimism with improved profitability measures and strategic growth plans. Valuation metrics are weak, showing financial distress. Overall, while there are positive signs from recent strategic moves, substantial risks remain.
To see Spark’s full report on SRXH stock, click here.
More about SRx Health Solutions
Average Trading Volume: 13,073,664
Technical Sentiment Signal: Strong Sell
Current Market Cap: $11.49M
Find detailed analytics on SRXH stock on TipRanks’ Stock Analysis page.